NIST leads and participates in multiple consortia as a form of public–private partnership. NIST plans to launch additional consortia for jointly developing new pre-competitive measurement solutions and standards for biotechnology and biomanufacturing.
Each NIST-Led consortium addresses a specific set of measurement challenges, typically organized around a platform technology such as flow cytometry, genome editing or rapid microbial testing. NIST also continues to connect various consortia to address sector-specific challenges to the accelerated manufacturing and streamlined testing needed for new biotechnology products to reach market.